Quipt Home Medical Corp. reiterates outlook for 2022. Based on the current operations, market trends and completed and prospective acquisitions, the Company is reiterating it outlook for its annual run-rate revenue by the end of calendar 2022 (Fiscal First Quarter 2023) to be $180-$190 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 CAD | 0.00% | +1.41% | -36.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.00% | 13Cr | |
+17.74% | 8.35TCr | |
-29.66% | 6.97TCr | |
0.00% | 2.65TCr | |
+3.06% | 1.77TCr | |
-12.16% | 1.68TCr | |
+2.47% | 1.57TCr | |
+74.82% | 1.34TCr | |
+0.76% | 1.27TCr | |
+73.52% | 1.28TCr |
- Stock Market
- Equities
- QIPT Stock
- News Quipt Home Medical Corp.
- Quipt Home Medical Corp. Reiterates Outlook for 2022